These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 37930439)
1. A promising anoikis-related prognostic signature predicts prognosis of skin cutaneous melanoma. Yue Z; Wang D; Li X J Cancer Res Clin Oncol; 2023 Dec; 149(20):17757-17770. PubMed ID: 37930439 [TBL] [Abstract][Full Text] [Related]
2. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma. Wu Z; Zhang R; Bao J; Yin M; Wang X Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413 [TBL] [Abstract][Full Text] [Related]
3. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma. Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879 [TBL] [Abstract][Full Text] [Related]
4. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature. Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598 [TBL] [Abstract][Full Text] [Related]
5. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma. Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients. Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434 [TBL] [Abstract][Full Text] [Related]
8. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
9. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma. Long S; Xu J; Huang H Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280 [TBL] [Abstract][Full Text] [Related]
10. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma. Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045 [TBL] [Abstract][Full Text] [Related]
11. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma. Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686 [TBL] [Abstract][Full Text] [Related]
12. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related]
13. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment. Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel disulfidptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients. Cheng S; Wang X; Yang S; Liang J; Song C; Zhu Q; Chen W; Ren Z; Zhu F Skin Res Technol; 2024 Jul; 30(7):e13814. PubMed ID: 38924611 [TBL] [Abstract][Full Text] [Related]
15. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Fan Y; Liang X; Yu D Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934 [TBL] [Abstract][Full Text] [Related]
16. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma. Liang L; Mai S; Mai G; Chen Y; Liu L Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812 [TBL] [Abstract][Full Text] [Related]
17. Transcriptome and single-cell transcriptomics reveal prognostic value and potential mechanism of anoikis in skin cutaneous melanoma. Liu X; Zhang HY; Deng HA Discov Oncol; 2024 Mar; 15(1):70. PubMed ID: 38460046 [TBL] [Abstract][Full Text] [Related]
18. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response. Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156 [TBL] [Abstract][Full Text] [Related]
19. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration. Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452 [TBL] [Abstract][Full Text] [Related]
20. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]